Home » Posts tagged 'indigovision'
Tag Archives: indigovision
Will Italy Do A Trump
Italy this weekend, hold the future of the Euro in its hands. Sundays referendum will show whether Italy is prepared to do a Trump and turn its back on its political establishment, whilst at the same time shaking the EU to its foundations. Massive support for Beppe Grillo the Clown Prince of Italian politics and leader of the Five Star movement could lead to the collapse of Italian Banks and a Euro crisis of huge proportions. Italian voters appear to be in no mood for half measures.
They have had enough and they have smelt blood, as they continue to watch their country’s economy destroyed, blighted by the Euro and the intransigence of the Eurozones unelected bureaucrats. Sterling has been rocketing ahead over the last few weeks, much to the chagrin of the EUs bitter and disappointed leaders. Come Monday morning the political establishment not just of Italy but of the whole EU could have received the biggest shock of their political lives, rejection by a core EU member, home of The Treaty of Rome.
Berkeley Group Holdings BKG Produced a 33% rise in profit before tax for the half year to 31st October and is increasing its interim dividend by 11%. Earnings per share rose by 35.2% and net cash almost doubled to to £207.9m after dividends and share purchases. Because of increased stamp duty and economic uncertainty arising from the referendum reservations are down 20% on the same time last year. The Chairman disagrees and claims that market conditions are resilient and forward sales are strong enabling the company to announce a new 5 year target of at least £3billion profit before tax in the five years from 1st May 2016. The present 3 year target of £2 billion pounds over the 3 years to April 2018 is being met. Time alone will tell whether the chairman is correct or whether the company is being impacted by uncertainty and market volatility.
James Halstead JHD is finding trading conditions are challenging and it will be difficult for it to beat the figures for the previous year. Revenue has continued to be below that of last year with the best estimate being that the shortfall could be as large as 4-5%. In particular Halstead has suffered from a shortage of plasticiser, one of its main ingredients, after an explosion at one of BASF; European plants which has led to delays, shortages and rising prices.
IndigoVision Group IND is experiencing a substantial turn round in its second half with revenues up 20% on those of the first half. In addition overheads are materially below last years and the company is now trading profitably after the first half’s losses. The full year to the end of December is now expected to end profitably.
Villas & Houses For Sale In The Greek Islands – visit; http://www.hiddengreece.net
Daily Actions – UK Main & AIM markets 29022016
Daily Actions is a daily summary analysis of changes in short term actions from our Daily Recs – AIM and Daily Recs Main markets reports. This report is typically distributed before the open of trading in London.
AIM Market
ST Rec. changed | ||
From | To | |
Basic Resources | ||
Ariana Resources | Buy | Neutral |
Chaarat Gold Holdings | Neutral | Buy |
Asa Resource Group | Neutral | Buy |
Uru Metals | Neutral | Buy |
Regency Mines | Neutral | Buy |
Paternoster Resources | Buy | Neutral |
Financial Services | ||
IPM | Buy | Neutral |
Manx Financial | Neutral | Buy |
Dragon-Ukrainian Properties & Development | Buy | Neutral |
Fletcher King | Neutral | Buy |
Impax Asset Management Group | Neutral | Buy |
RAB Special Situations Company | Buy | Strong Buy |
Food & Beverage | ||
PureCircle | Buy | Neutral |
Health Care | ||
Abcam | Sell | Neutral |
Industrial Good & Services | ||
APC Technology Group | Neutral | Buy |
Nakama Group | Neutral | Buy |
The Kellan Group | Neutral | Buy |
Ironveld | Buy | Neutral |
Petards Group | Neutral | Buy |
Oil & Gas – Explorers | ||
Bowleven | Buy | Neutral |
Chariot Oil & Gas | Buy | Neutral |
Oil & Gas – Producers | ||
Frontera Resources | Buy | Neutral |
Technology | ||
Indigovision Group | Neutral | Buy |
Pennant International Group | Neutral | Buy |
Simigon | Neutral | Buy |
Telecommunications | ||
Alternative Networks | Buy | Neutral |
Main Market
ST Rec. changed | ||
From | To | |
Banks | ||
Royal Bank of Scotland | Neutral | Buy |
Engineering & Machinery | ||
Rotork | Buy | Neutral |
Food Producers & Processors | ||
Associated British Foods | Sell | Neutral |
General Retail | ||
Burberry Group | Buy | Neutral |
Health | ||
Smith & Nephew | Sell | Neutral |
Personal Care & Household Products | ||
McBride | Sell | Neutral |
Speciality & Other Finance | ||
London Stock Exchange Group | Neutral | Sell |
Support Services | ||
John Menzies | Neutral | Sell |
Michael Page International | Buy | Neutral |
Transport | ||
Easyjet | Neutral | Buy |
RISK WARNING
Intellisys Intelligent Analysis Limited (‘Intellisys’) does not make personal recommendations. The information in this publication is provided solely to enable you to make your own investment decisions. If you are unsure about dealing in shares and other equity investments, you must contact your financial adviser as these types of investments may not be suitable for everyone. The value of stocks and shares, and the income from them, can fall as well as rise and you may not get back the full amount you originally invested. If denominated in a foreign currency, fluctuations in the exchange rate will also affect the value of stocks and shares and the income from them. Past performance is not necessarily a guide to future performance. You agree to abide fully with Intellisys’ Term & Conditions, which are available to www.intellisys.uk.com
The full reports are available from Intellisys Intelligent Analysis website (www.intellisys.uk.com) by clicking on the ‘Research’ tab.
DISCLAIMER: Intellisys Intelligent Analysis Limited has prepared this report. Intellisys (“Intellisys”) is the trading name of Intellisys Intelligent Analysis Limited. Intellisys Intelligent Analysis Limited is a provider of financial research reports that indicate the possible value of quoted company shares. The information contained within any and all of Intellisys’ reports are designed to present an objective assessment of the possible value or relative value of a company and/or an actuarial sector or stock market index. Intellisys utilises as extensive as possible range of valuation tools and proprietary systems to derive its outputs. The base data for the models are derived from sources believed to be accurate but Intellisys Intelligent Analysis Limited does not warrant or guarantee the accuracy or reliability of the source data or its models and proprietary systems. Subscribers, and casual readers, should not rely upon the Intellisys’ research outputs when forming specific investment decisions but should seek advice specific to their situation and investment requirements from a person authorised under the Financial Services and Markets Act 2000, before entering into any investment agreement.Intellisys Intelligent Analysis Limited has used reasonable care and skill in compiling the content of this report. No representation or warranty, expressed or implied, is given by any person as to the accuracy or completeness or accuracy of the information and no responsibility or liability is accepted to the accuracy or sufficiency of any of the information, for any errors, omissions or misstatements, negligent or otherwise. In no event will Intellisys Intelligent Analysis Limited, Intellisys or any of its officers, employees or agents be liable to any other party for any direct, indirect, special or other consequential damages arising from the use of this report.
The Intellisys Intelligent Analysis Limited and/or Intellisys reports are not directed to any person in any jurisdiction where (by reason of that person’s nationality, residence or otherwise) the publication or availability of the Intellisys Intelligent Analysis Limited and/or Intellisys information may be prohibited. Persons in respect of whom such prohibitions apply must not access the Intellisys Intelligent Analysis Limited and/or Intellisys reports. Neither this document, nor any copy in whatever form of media, may be taken or transmitted into the United States, Canada, Australia, Ireland, South Africa or Japan or into any jurisdiction where it would be unlawful to do so. Any failure to comply with this restriction may constitute a violation of relevant local securities laws. Recipients of Intellisys Intelligent Analysis Limited and/or Intellisys reports outside the UK are not covered by the rules and regulations made for the protection of investors in the UK. Any user distributing information taken from any Intellisys Intelligent Analysis Limited or Intellisys report and/or the Intellisys website, in whatever form, to any other person, agrees to attach a copy of this Disclaimer and the Terms and Conditions of Use pages and obtain the agreement of such other person to comply with the terms set forth. Intellisys’ published reports are published for information purposes and only available to market counterparties, high net-worth and sophisticated individual investors. No Intellisys report constitutes an offer or invitation to trade, sell, purchase or acquire any shares or other financial instruments in any company or any interest therein, nor shall it form the basis of any contract entered into for the sale of shares or any other financial instrument in any company. Intellisys Intelligent Analysis Limited believes that the information within each and any of its reports to be correct, but its accuracy or completeness cannot be guaranteed. No representation or warranty, expressed or implied, is given by any person as to the accuracy or completeness of the information and no responsibility or liability is accepted for the accuracy or sufficiency of any of the information, for any errors, omissions or mis-statements, negligent or otherwise. Intellisys Intelligent Analysis Limited (including its Directors, employees and representatives) or a connected person may have positions in or options or other financial instruments on any of the securities mentioned within a report, and may buy, sell or offer to purchase or sell such securities from time to time, subject to restrictions imposed by internal rules. Subscribers, and casual reader, are reminded that the value of any financial instrument may go up or down and that past performance is not necessarily a guide to future performance. Intellisys Intelligent Analysis Limited is not registered with or regulated by any financial regulatory authority and does not offer, provide or purport to provide or offer investment advice. Intellisys Intelligent Analysis Limited can be contacted at Woodfield Cottage, The Street, Mortimer, Berkshire, United Kingdom RG7 3DW. |
Daily Actions – UK Main & AIM markets 22012016
Daily Actions is a daily summary analysis of changes in short term actions from our Daily Recs – AIM and Daily Recs Main markets reports. This report is typically distributed before the open of trading in London.
AIM Market
ST Rec. changed | ||
From | To | |
Basic Resources | ||
Condor Gold | Buy | Neutral |
James Cropper | Sell | Neutral |
Petropavlovsk | Neutral | Sell |
Serabi Gold | Neutral | Buy |
Financial Services | ||
Amphion Innovations | Neutral | Buy |
FastForward Innovations | Neutral | Buy |
LondonMetric Property | Buy | Neutral |
RAB Special Situations Company | Buy | Strong Buy |
Starvest | Buy | Neutral |
Food & Beverage | ||
Real Good Food Company | Buy | Neutral |
Health Care | ||
AorTech International | Buy | Neutral |
Eco Animal Health Group | Sell | Neutral |
Industrial Good & Services | ||
Gooch & Housego | Sell | Neutral |
Hydro International | Sell | Neutral |
Impellam Group | Sell | Neutral |
James Latham | Sell | Neutral |
Kennedy Ventures | Neutral | Buy |
NWF Group | Sell | Neutral |
Media | ||
Dods Group | Neutral | Buy |
Oil & Gas – Producers | ||
Victoria Oil & Gas | Strong Buy | Buy |
Technology | ||
Access Intelligence | Sell | Neutral |
Indigovision Group | Neutral | Buy |
Telecommunications | ||
Avanti Communications Group | Strong Buy | Buy |
Travel & Leisure | ||
Best of the Best | Sell | Neutral |
Main Market
ST Rec. changed | ||
From | To | |
Beverages | ||
SAB Miller | Sell | Neutral |
Engineering & Machinery | ||
Castings | Sell | Neutral |
Vesuvius | Buy | Neutral |
Hill & Smith | Sell | Neutral |
Vitec Group | Neutral | Buy |
Weir Group | Buy | Neutral |
Food Producers & Processors | ||
Cranswick | Sell | Neutral |
Insurance | ||
Jardine Lloyd Thompson | Neutral | Buy |
Leisure & Hotels | ||
Mitchells & Butlers | Buy | Neutral |
JD Wetherspoon | Buy | Neutral |
Media & Entertainment | ||
Informa | Neutral | Sell |
St. Ives | Sell | Neutral |
Personal Care & Household Products | ||
McBride | Sell | Neutral |
Reckitt Benckiser Group | Sell | Neutral |
Pharmaceuticals & Biotechnology | ||
BTG | Buy | Neutral |
Ixico | Buy | Neutral |
Real Estate – REIS | ||
CLS Holdings | Buy | Neutral |
J Smart | Sell | Neutral |
St. Modwen Properties | Buy | Neutral |
Speciality & Other Finance | ||
Aberdeen Asset Management | Buy | Neutral |
Support Services | ||
Aggreko | Buy | Neutral |
AMEC Foster Wheeler | Buy | Neutral |
Compass Group | Sell | Neutral |
Berendsen | Sell | Neutral |
Michael Page International | Neutral | Buy |
Rexam | Sell | Neutral |
Utilities | ||
National Grid | Sell | Neutral |
Severn Trent | Sell | Neutral |
United Utilities Group | Sell | Neutral |
RISK WARNING
Intellisys Intelligent Analysis Limited (‘Intellisys’) does not make personal recommendations. The information in this publication is provided solely to enable you to make your own investment decisions. If you are unsure about dealing in shares and other equity investments, you must contact your financial adviser as these types of investments may not be suitable for everyone. The value of stocks and shares, and the income from them, can fall as well as rise and you may not get back the full amount you originally invested. If denominated in a foreign currency, fluctuations in the exchange rate will also affect the value of stocks and shares and the income from them. Past performance is not necessarily a guide to future performance. You agree to abide fully with Intellisys’ Term & Conditions, which are available to www.intellisys.uk.com
The full reports are available from Intellisys Intelligent Analysis website (www.intellisys.uk.com) by clicking on the ‘Research’ tab.
DISCLAIMER: Intellisys Intelligent Analysis Limited has prepared this report. Intellisys (“Intellisys”) is the trading name of Intellisys Intelligent Analysis Limited. Intellisys Intelligent Analysis Limited is a provider of financial research reports that indicate the possible value of quoted company shares. The information contained within any and all of Intellisys’ reports are designed to present an objective assessment of the possible value or relative value of a company and/or an actuarial sector or stock market index. Intellisys utilises as extensive as possible range of valuation tools and proprietary systems to derive its outputs. The base data for the models are derived from sources believed to be accurate but Intellisys Intelligent Analysis Limited does not warrant or guarantee the accuracy or reliability of the source data or its models and proprietary systems. Subscribers, and casual readers, should not rely upon the Intellisys’ research outputs when forming specific investment decisions but should seek advice specific to their situation and investment requirements from a person authorised under the Financial Services and Markets Act 2000, before entering into any investment agreement.Intellisys Intelligent Analysis Limited has used reasonable care and skill in compiling the content of this report. No representation or warranty, expressed or implied, is given by any person as to the accuracy or completeness or accuracy of the information and no responsibility or liability is accepted to the accuracy or sufficiency of any of the information, for any errors, omissions or misstatements, negligent or otherwise. In no event will Intellisys Intelligent Analysis Limited, Intellisys or any of its officers, employees or agents be liable to any other party for any direct, indirect, special or other consequential damages arising from the use of this report.The Intellisys Intelligent Analysis Limited and/or Intellisys reports are not directed to any person in any jurisdiction where (by reason of that person’s nationality, residence or otherwise) the publication or availability of the Intellisys Intelligent Analysis Limited and/or Intellisys information may be prohibited. Persons in respect of whom such prohibitions apply must not access the Intellisys Intelligent Analysis Limited and/or Intellisys reports. Neither this document, nor any copy in whatever form of media, may be taken or transmitted into the United States, Canada, Australia, Ireland, South Africa or Japan or into any jurisdiction where it would be unlawful to do so. Any failure to comply with this restriction may constitute a violation of relevant local securities laws. Recipients of Intellisys Intelligent Analysis Limited and/or Intellisys reports outside the UK are not covered by the rules and regulations made for the protection of investors in the UK.
Any user distributing information taken from any Intellisys Intelligent Analysis Limited or Intellisys report and/or the Intellisys website, in whatever form, to any other person, agrees to attach a copy of this Disclaimer and the Terms and Conditions of Use pages and obtain the agreement of such other person to comply with the terms set forth. Intellisys’ published reports are published for information purposes and only available to market counterparties, high net-worth and sophisticated individual investors. No Intellisys report constitutes an offer or invitation to trade, sell, purchase or acquire any shares or other financial instruments in any company or any interest therein, nor shall it form the basis of any contract entered into for the sale of shares or any other financial instrument in any company. Intellisys Intelligent Analysis Limited believes that the information within each and any of its reports to be correct, but its accuracy or completeness cannot be guaranteed. No representation or warranty, expressed or implied, is given by any person as to the accuracy or completeness of the information and no responsibility or liability is accepted for the accuracy or sufficiency of any of the information, for any errors, omissions or mis-statements, negligent or otherwise. Intellisys Intelligent Analysis Limited (including its Directors, employees and representatives) or a connected person may have positions in or options or other financial instruments on any of the securities mentioned within a report, and may buy, sell or offer to purchase or sell such securities from time to time, subject to restrictions imposed by internal rules. Subscribers, and casual reader, are reminded that the value of any financial instrument may go up or down and that past performance is not necessarily a guide to future performance. Intellisys Intelligent Analysis Limited is not registered with or regulated by any financial regulatory authority and does not offer, provide or purport to provide or offer investment advice. Intellisys Intelligent Analysis Limited can be contacted at Woodfield Cottage, The Street, Mortimer, Berkshire, United Kingdom RG7 3DW. |
Daily Actions – UK Main & AIM markets 19012016
Daily Actions is a daily summary analysis of changes in short term actions from our Daily Recs – AIM and Daily Recs Main markets reports. This report is typically distributed before the open of trading in London.
AIM Market
ST Rec. changed | ||
From | To | |
Basic Resources | ||
Amur Minerals Corporation | Neutral | Buy |
Avocet Mining | Sell | Neutral |
Metals Exploration | Neutral | Buy |
Patagonia Gold | Neutral | Buy |
Chemicals | ||
Plant Healthcare | Buy | Neutral |
Financial Services | ||
FastForward Innovations | Neutral | Buy |
Dragon-Ukrainian Properties & Development | Buy | Neutral |
LondonMetric Property | Neutral | Buy |
Raven Russia | Buy | Neutral |
Health Care | ||
AorTech International | Buy | Neutral |
Epistem Holdings | Neutral | Buy |
Industrial Good & Services | ||
Ceres Power Holdings | Buy | Neutral |
Impellam Group | Sell | Neutral |
MobilityOne | Buy | Neutral |
Oil & Gas – Explorers | ||
Ascent Resources | Neutral | Buy |
Oil & Gas – Producers | ||
Plexus Holdings | Neutral | Buy |
Technology | ||
Indigovision Group | Neutral | Buy |
Tern | Neutral | Buy |
Toumaz | Buy | Neutral |
Main Market
ST Rec. changed | ||
From | To | |
Banks | ||
HSBC | Neutral | Buy |
Heavy Construction | ||
Henry Boot | Sell | Neutral |
House Construction | ||
Bovis Homes Group | Neutral | Buy |
Electronics & Electrical Equipment | ||
Spectris | Neutral | Buy |
Engineering & Machinery | ||
Castings | Neutral | Sell |
Fenner | Buy | Neutral |
Hill & Smith | Sell | Neutral |
Morgan Advanced Material | Neutral | Buy |
Food Producers & Processors | ||
Cranswick | Sell | Neutral |
General Retail | ||
JD Sports Fashion | Sell | Neutral |
Health | ||
Bioquell | Neutral | Sell |
Household Goods & Textiles | ||
Headlam Group | Sell | Neutral |
Leisure & Hotels | ||
Mitchells & Butlers | Neutral | Buy |
Life Assurance | ||
Chesnara | Neutral | Sell |
Media & Entertainment | ||
Informa | Sell | Neutral |
St. Ives | Sell | Neutral |
Oil & Gas | ||
JKX Oil & Gas | Neutral | Sell |
Pharmaceuticals & Biotechnology | ||
Oxford Biomedica | Neutral | Buy |
Support Services | ||
Michael Page International | Neutral | Buy |
Rexam | Sell | Neutral |
Telecommunication Services | ||
BT Group | Sell | Neutral |
Utilities | ||
National Grid | Sell | Neutral |
RISK WARNING
Intellisys Intelligent Analysis Limited (‘Intellisys’) does not make personal recommendations. The information in this publication is provided solely to enable you to make your own investment decisions. If you are unsure about dealing in shares and other equity investments, you must contact your financial adviser as these types of investments may not be suitable for everyone. The value of stocks and shares, and the income from them, can fall as well as rise and you may not get back the full amount you originally invested. If denominated in a foreign currency, fluctuations in the exchange rate will also affect the value of stocks and shares and the income from them. Past performance is not necessarily a guide to future performance. You agree to abide fully with Intellisys’ Term & Conditions, which are available to www.intellisys.uk.com
The full reports are available from Intellisys Intelligent Analysis website (www.intellisys.uk.com) by clicking on the ‘Research’ tab.
DISCLAIMER: Intellisys Intelligent Analysis Limited has prepared this report. Intellisys (“Intellisys”) is the trading name of Intellisys Intelligent Analysis Limited. Intellisys Intelligent Analysis Limited is a provider of financial research reports that indicate the possible value of quoted company shares. The information contained within any and all of Intellisys’ reports are designed to present an objective assessment of the possible value or relative value of a company and/or an actuarial sector or stock market index. Intellisys utilises as extensive as possible range of valuation tools and proprietary systems to derive its outputs. The base data for the models are derived from sources believed to be accurate but Intellisys Intelligent Analysis Limited does not warrant or guarantee the accuracy or reliability of the source data or its models and proprietary systems. Subscribers, and casual readers, should not rely upon the Intellisys’ research outputs when forming specific investment decisions but should seek advice specific to their situation and investment requirements from a person authorised under the Financial Services and Markets Act 2000, before entering into any investment agreement.Intellisys Intelligent Analysis Limited has used reasonable care and skill in compiling the content of this report. No representation or warranty, expressed or implied, is given by any person as to the accuracy or completeness or accuracy of the information and no responsibility or liability is accepted to the accuracy or sufficiency of any of the information, for any errors, omissions or misstatements, negligent or otherwise. In no event will Intellisys Intelligent Analysis Limited, Intellisys or any of its officers, employees or agents be liable to any other party for any direct, indirect, special or other consequential damages arising from the use of this report.
The Intellisys Intelligent Analysis Limited and/or Intellisys reports are not directed to any person in any jurisdiction where (by reason of that person’s nationality, residence or otherwise) the publication or availability of the Intellisys Intelligent Analysis Limited and/or Intellisys information may be prohibited. Persons in respect of whom such prohibitions apply must not access the Intellisys Intelligent Analysis Limited and/or Intellisys reports. Neither this document, nor any copy in whatever form of media, may be taken or transmitted into the United States, Canada, Australia, Ireland, South Africa or Japan or into any jurisdiction where it would be unlawful to do so. Any failure to comply with this restriction may constitute a violation of relevant local securities laws. Recipients of Intellisys Intelligent Analysis Limited and/or Intellisys reports outside the UK are not covered by the rules and regulations made for the protection of investors in the UK. Any user distributing information taken from any Intellisys Intelligent Analysis Limited or Intellisys report and/or the Intellisys website, in whatever form, to any other person, agrees to attach a copy of this Disclaimer and the Terms and Conditions of Use pages and obtain the agreement of such other person to comply with the terms set forth. Intellisys’ published reports are published for information purposes and only available to market counterparties, high net-worth and sophisticated individual investors. No Intellisys report constitutes an offer or invitation to trade, sell, purchase or acquire any shares or other financial instruments in any company or any interest therein, nor shall it form the basis of any contract entered into for the sale of shares or any other financial instrument in any company. Intellisys Intelligent Analysis Limited believes that the information within each and any of its reports to be correct, but its accuracy or completeness cannot be guaranteed. No representation or warranty, expressed or implied, is given by any person as to the accuracy or completeness of the information and no responsibility or liability is accepted for the accuracy or sufficiency of any of the information, for any errors, omissions or mis-statements, negligent or otherwise. Intellisys Intelligent Analysis Limited (including its Directors, employees and representatives) or a connected person may have positions in or options or other financial instruments on any of the securities mentioned within a report, and may buy, sell or offer to purchase or sell such securities from time to time, subject to restrictions imposed by internal rules. Subscribers, and casual reader, are reminded that the value of any financial instrument may go up or down and that past performance is not necessarily a guide to future performance. Intellisys Intelligent Analysis Limited is not registered with or regulated by any financial regulatory authority and does not offer, provide or purport to provide or offer investment advice. Intellisys Intelligent Analysis Limited can be contacted at Woodfield Cottage, The Street, Mortimer, Berkshire, United Kingdom RG7 3DW. |